Table 1 Characterization of MTM-loaded nanodevices
From: Mithramycin delivery systems to develop effective therapies in sarcomas
Formulation | RH, (nm) | PDI | Z-Potential (mV) | EE% | LE% |
|---|---|---|---|---|---|
MTM-NPs | 158.9 ± 0.9 | 0.16 ± 0.1 | −31.9 ± 0.9 | 22.7 ± 2.5 | 3.1 ± 1.7 |
MTM-LIP | 81.1 ± 0.2 | 0.08 ± 0.1 | −27.6 ± 0.9 | 92.49 ± 1.5 | 35 ± 0.4 |
NPs | 75.5 ± 0.5 | 0.1 ± 0.1 | −24.5 ± 0.5 | – | – |
LIP | 86.9 ± 0.8 | 0.1 ± 0.1 | −17.1 ± 1.7 | – | – |